DR. KADE is a medium-sized German specialty pharmaceutical company based in Berlin and Constance. The company has been owned by one family for four generations and can look back on a tradition of more than 120 years.

The company specializes in manufacturing and marketing drugs in the fields of gynecology, proctology and pain/rheumatism. The potential of well-proven active pharmaceutical ingredients is systematically developed by galenic research and realized in innovative products. These processes make use of the latest findings in medicinal and pharmaceutical science. Based on intensive cooperation with competent partners abroad, our products are successfully marketed not only in Germany, but also in Asia, as well as Central and Eastern Europe.

DR. KADE has been the leading manufacturer of anti-hemorrhoidal products for many years with a market share of almost 30% in Germany, Japan and numerous other countries. Following a targeted expansion of its product range, the company also has a leading position in the field of gynecology. The success of DR. KADE is based primarily on the commitment of 360 employees. Their motivation and creativity are an essential prerequisite for meeting the high quality standards demanded by global competition. DR. KADE offers a strong target group sales force for gynecologist, pain specialists and pharmacies in Germany.

DR. KADE is looking for  licensing partner for Cliovelle^® tablets - a low dose Estrogen/Progestin oral combination product for the continuous Hormone Replacement Therapy (HRT). Marketing Authorization in Europe is granted.

The product is available for licensing, marketing and distribution in certain territories except Germany, Poland, Scandinavia, Czech Republic and Slovakia.

DR. KADE is interested in licensing products in Female Healtcare and Pain treatment for Germany.